13-110524008-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_017817.3(RAB20):c.362G>A(p.Gly121Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000458 in 1,614,046 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017817.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAB20 | NM_017817.3 | c.362G>A | p.Gly121Glu | missense_variant | 2/2 | ENST00000267328.5 | NP_060287.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAB20 | ENST00000267328.5 | c.362G>A | p.Gly121Glu | missense_variant | 2/2 | 1 | NM_017817.3 | ENSP00000267328 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152186Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000334 AC: 84AN: 251388Hom.: 1 AF XY: 0.000339 AC XY: 46AN XY: 135878
GnomAD4 exome AF: 0.000471 AC: 689AN: 1461860Hom.: 1 Cov.: 30 AF XY: 0.000454 AC XY: 330AN XY: 727236
GnomAD4 genome AF: 0.000335 AC: 51AN: 152186Hom.: 1 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2022 | The c.362G>A (p.G121E) alteration is located in exon 2 (coding exon 2) of the RAB20 gene. This alteration results from a G to A substitution at nucleotide position 362, causing the glycine (G) at amino acid position 121 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at